| Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta‐analysis and systematic review JP Schacht, RF Anton, H Myrick Addiction biology 18 (1), 121-133, 2013 | 573 | 2013 |
| Marijuana craving in the brain FM Filbey, JP Schacht, US Myers, RS Chavez, KE Hutchison Proceedings of the National Academy of Sciences 106 (31), 13016-13021, 2009 | 267 | 2009 |
| Neural substrates of cue reactivity: association with treatment outcomes and relapse KE Courtney, JP Schacht, K Hutchison, DJO Roche, LA Ray Addiction biology 21 (1), 3-22, 2016 | 215 | 2016 |
| Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes HM Haughey, E Marshall, JP Schacht, A Louis, KE Hutchison Addiction 103 (10), 1678-1686, 2008 | 167 | 2008 |
| Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users JP Schacht, KE Hutchison, FM Filbey Neuropsychopharmacology 37 (11), 2368-2376, 2012 | 142 | 2012 |
| Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues FM Filbey, JP Schacht, US Myers, RS Chavez, KE Hutchison Neuropsychopharmacology 35 (4), 967-975, 2010 | 138 | 2010 |
| The incentive salience of alcohol: translating the effects of genetic variant in CNR1 KE Hutchison, H Haughey, M Niculescu, J Schacht, A Kaiser, J Stitzel, ... Archives of general psychiatry 65 (7), 841-850, 2008 | 114 | 2008 |
| COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review JP Schacht The pharmacogenomics journal 16 (5), 430-438, 2016 | 110 | 2016 |
| Predictors of naltrexone response in a randomized trial: reward-related brain activation, OPRM1 genotype, and smoking status JP Schacht, PK Randall, PK Latham, KE Voronin, SW Book, H Myrick, ... Neuropsychopharmacology 42 (13), 2640-2653, 2017 | 97 | 2017 |
| Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues JP Schacht, RF Anton, KE Voronin, PK Randall, X Li, S Henderson, ... Neuropsychopharmacology 38 (3), 414-422, 2013 | 94 | 2013 |
| Stability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach JP Schacht, RF Anton, PK Randall, X Li, S Henderson, H Myrick Neuroimage 56 (1), 61-68, 2011 | 85 | 2011 |
| Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis JP Schacht, RE Selling, KE Hutchison Psychopharmacology 203, 511-517, 2009 | 76 | 2009 |
| Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals JP Schacht, RF Anton, PK Randall, X Li, S Henderson, H Myrick Psychopharmacology 231, 3799-3807, 2014 | 53 | 2014 |
| A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus H Ekhtiari, M Zare-Bidoky, A Sangchooli, AC Janes, MJ Kaufman, ... Nature Protocols 17 (3), 567-595, 2022 | 50 | 2022 |
| Investigating a novel fMRI cannabis cue reactivity task in youth HC Karoly, JP Schacht, LR Meredith, J Jacobus, SF Tapert, KM Gray, ... Addictive behaviors 89, 20-28, 2019 | 43 | 2019 |
| Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics JP Schacht, RF Anton, PK Randall, X Li, S Henderson, H Myrick Psychopharmacology 227, 627-637, 2013 | 38 | 2013 |
| Aripiprazole suppression of drinking in a clinical laboratory paradigm: influence of impulsivity and self‐control RF Anton, JP Schacht, KE Voronin, PK Randall Alcoholism: Clinical and Experimental Research 41 (7), 1370-1380, 2017 | 37 | 2017 |
| Brain glutamate, GABA, and glutamine levels and associations with recent drinking in treatment‐naive individuals with alcohol use disorder versus light drinkers JJ Prisciandaro, JP Schacht, AP Prescot, PF Renshaw, TR Brown, ... Alcoholism: Clinical and Experimental Research 43 (2), 221-226, 2019 | 34 | 2019 |
| Systematic review and meta‐analysis of the moderating effect of rs1799971 in OPRM1, the mu‐opioid receptor gene, on response to naltrexone treatment of … EE Hartwell, R Feinn, PE Morris, J Gelernter, J Krystal, AJ Arias, ... Addiction 115 (8), 1426-1437, 2020 | 33 | 2020 |
| Nicotine‐use/smoking is associated with the efficacy of naltrexone in the treatment of alcohol dependence RF Anton, PK Latham, KE Voronin, PK Randall, SW Book, M Hoffman, ... Alcoholism: Clinical and Experimental Research 42 (4), 751-760, 2018 | 33 | 2018 |
Kent E HutchisonUniversity of Colorado at Boulder在 colorado.edu 的电子邮件经过验证
